Published in J Med Genet on December 01, 2004
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab (2009) 2.23
Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet (2013) 2.21
Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors. Cancer Res (2008) 1.39
The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits. J Clin Endocrinol Metab (2009) 1.15
Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice. PLoS Genet (2010) 1.09
How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues? Mol Cell Endocrinol (2010) 1.09
An immortalized human cell line bearing a PRKAR1A-inactivating mutation: effects of overexpression of the wild-type Allele and other protein kinase A subunits. J Clin Endocrinol Metab (2007) 1.07
The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis. J Med Genet (2005) 1.07
Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling. Hum Mol Genet (2010) 1.05
Carney complex: an update. Eur J Endocrinol (2015) 1.04
Alternate protein kinase A activity identifies a unique population of stromal cells in adult bone. Proc Natl Acad Sci U S A (2010) 1.04
Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A. Mol Endocrinol (2007) 1.03
cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse. Mol Cell Endocrinol (2013) 0.97
Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathol (2011) 0.95
A novel PRKAR1A mutation associated with hepatocellular carcinoma in a young patient and a variable Carney complex phenotype in affected subjects in older generations. Clin Endocrinol (Oxf) (2008) 0.91
The cAMP pathway and the control of adrenocortical development and growth. Mol Cell Endocrinol (2011) 0.90
Role of nonselective cation channels in spontaneous and protein kinase A-stimulated calcium signaling in pituitary cells. Am J Physiol Endocrinol Metab (2011) 0.90
The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors. Endocr Pract (2011) 0.88
The transcriptome that mediates increased cyclic adenosine monophosphate signaling in PRKAR1A defects and other settings. Endocr Pract (2011) 0.88
GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population. Med Oncol (2014) 0.86
Knockdown of PRKAR1A, the gene responsible for Carney complex, interferes with differentiation in osteoblastic cells. Mol Endocrinol (2014) 0.84
Regulation of the adrenocortical stem cell niche: implications for disease. Nat Rev Endocrinol (2014) 0.84
High expression of metabotropic glutamate receptor 4: correlation with clinicopathologic characteristics and prognosis of osteosarcoma. J Cancer Res Clin Oncol (2014) 0.84
Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families. J Clin Endocrinol Metab (2009) 0.84
Anxiety phenotype in mice that overexpress protein kinase A. Psychoneuroendocrinology (2011) 0.83
Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma. Front Endocrinol (Lausanne) (2012) 0.83
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies. Crit Rev Oncog (2015) 0.81
Unraveling the molecular basis of micronodular adrenal hyperplasia. Curr Opin Endocrinol Diabetes Obes (2008) 0.80
Threat bias in mice with inactivating mutations of Prkar1a. Neuroscience (2013) 0.77
Does somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation. J Clin Endocrinol Metab (2014) 0.76
PRKAR1A gene analysis and protein kinase A activity in endometrial tumors. Endocr Relat Cancer (2012) 0.76
Inactivation of the Carney complex gene 1 (PRKAR1A) alters spatiotemporal regulation of cAMP and cAMP-dependent protein kinase: a study using genetically encoded FRET-based reporters. Hum Mol Genet (2013) 0.76
Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking? Front Endocrinol (Lausanne) (2016) 0.75
Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia. Endocr Relat Cancer (2015) 0.75
Carney complex: A familial lentiginosis predisposing to a variety of tumors. Rev Endocr Metab Disord (2016) 0.75
An in vivo screening system to identify tumorigenic genes. Oncogene (2016) 0.75
How the new tools to analyze the human genome are opening new perspectives: the use of gene expression in investigations of the adrenal cortex. Ann Endocrinol (Paris) (2008) 0.75
8-Cl-adenosine inhibits proliferation and causes apoptosis in B-lymphocytes via protein kinase A-dependent and independent effects: implications for treatment of Carney complex-associated tumors. J Clin Endocrinol Metab (2009) 0.75
Prkar1a gene knockout in the pancreas leads to neuroendocrine tumorigenesis. Endocr Relat Cancer (2016) 0.75
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54
Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet (2000) 6.26
Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab (2001) 4.42
Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer (2003) 3.23
Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum Mol Genet (2000) 2.73
Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex) J Clin Endocrinol Metab (1997) 2.14
Cyclic nucleotide-dependent protein kinases. Pharmacol Ther (1991) 1.94
Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res (2003) 1.82
Compensatory regulation of RIalpha protein levels in protein kinase A mutant mice. J Biol Chem (1997) 1.80
Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med (1999) 1.79
The essential role of RI alpha in the maintenance of regulated PKA activity. Ann N Y Acad Sci (2002) 1.70
Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab (2002) 1.59
Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo. J Biol Chem (2002) 1.52
Cyclic AMP, PKA, and the physiological regulation of adiposity. Recent Prog Horm Res (1998) 1.38
Protein kinase A and its role in human neoplasia: the Carney complex paradigm. Endocr Relat Cancer (2004) 1.38
Carney complex: the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Semin Dermatol (1995) 1.37
cAMP-dependent protein kinase: role in normal and malignant growth. Crit Rev Oncol Hematol (1995) 1.33
Analysis of the cAMP-dependent protein kinase system using molecular genetic approaches. Recent Prog Horm Res (1988) 1.20
Cervical presentations of thymic anomalies in children. Int J Pediatr Otorhinolaryngol (2004) 1.20
Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer. Genes Chromosomes Cancer (2002) 1.18
Recent insights into organogenesis of the adrenal cortex. Trends Endocrinol Metab (2002) 1.11
The role of cAMP in regulating tumour cell growth. Cancer Surv (1986) 0.93
Ductal adenoma of the breast and the Carney complex. Am J Surg Pathol (1996) 0.85
Cyclic AMP-dependent protein kinase isoenzymes in human myeloid leukemia (HL60) and breast tumor (MCF-7) cells. Arch Biochem Biophys (2001) 0.84
Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells. J Cell Physiol (2000) 0.83
Computed tomography appearance of the thymus and anterior mediastinum in active Cushing's syndrome. J Clin Endocrinol Metab (1999) 0.82
Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment. Front Biosci (1999) 0.82
Molecular genetic analysis of cAMP-dependent protein kinase. Ann N Y Acad Sci (1986) 0.81
Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet (2000) 6.26
The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) (1985) 4.64
Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab (2001) 4.42
Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77
An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A (2001) 3.14
Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology (1999) 2.75
Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum Mol Genet (2000) 2.73
Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. N Engl J Med (1989) 2.42
Skip lesions in temporal arteritis. Mayo Clin Proc (1976) 2.37
Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation (1998) 2.21
Behçet's disease. Report of 10 cases, 3 with new manifestations. Ann Intern Med (1971) 2.20
Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex) J Clin Endocrinol Metab (1997) 2.14
Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc (1986) 2.13
The significance of multiple, recurrent, and "complex" cardiac myxomas. J Thorac Cardiovasc Surg (1986) 2.12
The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med (1977) 2.07
Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res (1998) 2.06
Did the Chernobyl incident cause an increase in Type 1 diabetes mellitus incidence in children and adolescents? Diabetologia (2003) 2.05
Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc (1983) 2.01
Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg (1998) 2.00
Use of slide latex agglutination test for rapid diagnosis of vaginal candidosis. Genitourin Med (1987) 2.00
Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest (1996) 1.94
Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab (2001) 1.91
Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders. Am J Surg Pathol (2001) 1.90
Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg (1996) 1.88
Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am J Transplant (2008) 1.86
Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore) (1992) 1.84
Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med (1999) 1.79
Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy. J Clin Endocrinol Metab (2000) 1.76
Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A (2003) 1.74
Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol (1998) 1.70
Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology (2000) 1.69
Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery (1985) 1.64
Carney complex, Peutz-Jeghers syndrome, Cowden disease, and Bannayan-Zonana syndrome share cutaneous and endocrine manifestations, but not genetic loci. J Clin Endocrinol Metab (1998) 1.63
Adrenocortical tumors in children. Braz J Med Biol Res (2000) 1.60
Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b. N Engl J Med (1976) 1.59
Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev (1998) 1.58
Origin and spread of slow waves in canine gastric antral circular muscle. Am J Physiol (1985) 1.51
Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc Natl Acad Sci U S A (2000) 1.50
Feedback control of rat liver tryptophan pyrrolase. I. End product inhibition of trytophan pyrrolase activity. J Biol Chem (1967) 1.49
Criteria for the diagnosis of vaginal candidosis: evaluation of a new latex agglutination test. Eur J Obstet Gynecol Reprod Biol (1986) 1.48
SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med (2009) 1.47
Differences between nonfamilial and familial cardiac myxoma. Am J Surg Pathol (1985) 1.47
Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery (1988) 1.44
Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology (2001) 1.44
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet (2005) 1.44
Molecular mechanisms of insulin resistance. Diabet Med (2005) 1.42
Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes. Diabetologia (2003) 1.41
Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J (2012) 1.40
Hyperleptinaemia does not correlate with plasma catecholamine levels in chronic heart failure. Eur Heart J (1999) 1.38
Protein kinase A and its role in human neoplasia: the Carney complex paradigm. Endocr Relat Cancer (2004) 1.38
Duodenal gangliocytic paraganglioma. Clinicopathologic and immunocytochemical study of 11 cases. Am J Clin Pathol (1986) 1.37
Slow wave heterogeneity within the circular muscle of the canine gastric antrum. J Physiol (1985) 1.35
Cutaneous myxomas. A major component of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Arch Dermatol (1986) 1.35
Effect of nitric oxide on circular muscle of the canine small intestine. J Physiol (1991) 1.34
Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol (1987) 1.33
LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol (1999) 1.32
Antisense DNAs as multisite genomic modulators identified by DNA microarray. Proc Natl Acad Sci U S A (2001) 1.32
Neurosurgical implications of Carney complex. J Neurosurg (2000) 1.30
The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paraganglioma: a five-year review. Medicine (Baltimore) (1983) 1.30
Neoplasms metastatic to the thyroid gland. Surg Gynecol Obstet (1982) 1.30
Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am J Physiol (1997) 1.29
Rapid diagnosis of vaginal candidosis by latex particle agglutination. J Clin Pathol (1985) 1.28
Multiple endocrine neoplasia type 2. Clin Endocrinol Metab (1980) 1.28
Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab (1993) 1.26
Carney complex: diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas. Am J Med Genet (1998) 1.25
The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab (1998) 1.25
Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am J Surg Pathol (1984) 1.25
Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med (2000) 1.24
Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Pathol (1987) 1.24
Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery (1999) 1.24
Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res (1998) 1.23
Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21. Am J Hum Genet (1999) 1.23
Leukocytes of the intestinal muscularis: their phenotype and isolation. J Leukoc Biol (1998) 1.22
Carcinoid tumor of the thymus: a clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc (1980) 1.22
Genetic heterogeneity in Peutz-Jeghers syndrome. Hum Mutat (2000) 1.22
Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth. J Biol Chem (1999) 1.20
Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest (1991) 1.18
Metastatic tumors to testicles: routes of metastasis. J Urol (1969) 1.18
Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci (1987) 1.17
Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas. Horm Metab Res (2008) 1.17
Cyclic AMP-binding proteins: inverse relationship with estrogen-receptors in hormone-dependent mammary tumor regression. Eur J Biochem (1978) 1.16
The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med (1983) 1.15